Cancer research at BESSY II: Binding Mechanisms of Therapeutic Substances Deciphered
The study is displayed on the cover of the journal Chemmedchem. © Chemmedchem/VCH Wiley
In tumor cells, the DNA is altered in comparison to normal body cells. How such changes can be prevented or inhibited is an exciting field of research with great relevance for the development of cancer treatments. An interdisciplinary team has now analysed the possible binding mechanisms in certain therapeutic substances from the tetrazole hydrazide group using protein crystallography at BESSY II.
Certain proteins such as human histone demethylases, including the KDM4 protein, play a role in the development of tumour cells. They bind to the DNA and modify it so that the cell can become cancerous. Therapeutic substances that are able to inhibit or even reverse such changes are of particular interest.
Biochemist Prof. Dr. Udo Heinemann from the Max Delbrück Centre in Berlin-Buch is investigating such processes. In cooperation with chemists led by Prof. Dr. Andreas Link from the University of Greifswald and the team led by Dr. Manfred Weiss at the HZB, he has now investigated how and where certain therapeutic substances from the tetrazole hydrazide group dock to these protein molecules and thus inhibit their harmful effect.
KDM4 protein crystals analysed
Link initially produced variations of tetrazole hydrazide substances. For structural analysis, crystals had to be grown from KDM4 proteins - a difficult task that Dr. Piotr Malecki and Manfred Weiss had taken on at the HZB. The KDM4 protein crystals were then soaked in a specific substance before being analyzed with strong X-rays on the MX beamlines of BESSY II. A refined analysis showed not only the three-dimensional architecture of the KDM4 protein, but also exactly where the active substances had docked to the KDM4 molecule.
"This class of substances has not yet been structurally investigated," explains Manfred Weiss. And Udo Heinemann from the MDC explains: "We will now evaluate where there are opportunities to dock even stronger within the 3D structure of the KDM4. Then we might also be able to develop drugs that inhibit the KDM4 even more and thus have the potential to become a therapeutic."
- Spintronics at BESSY II: Domain walls in magnetic nanowiresMagnetic domains walls are known to be a source of electrical resistance due to the difficulty for transport electron spins to follow their magnetic texture. This phenomenon holds potential for utilization in spintronic devices, where the electrical resistance can vary based on the presence or absence of a domain wall. A particularly intriguing class of materials are half metals such as La2/3Sr1/3MnO3 (LSMO) which present full spin polarization, allowing their exploitation in spintronic devices. Still the resistance of a single domain wall in half metals remained unknown. Now a team from Spain, France and Germany has generated a single domain wall on a LSMO nanowire and measured resistance changes 20 times larger than for a normal ferromagnet such as Cobalt.
- Fractons as information storage: Not yet quite tangible, but closeA new quasiparticle with interesting properties has appeared in solid-state physics - but so far only in the theoretical modelling of solids with certain magnetic properties. An international team from HZB and Freie Universität Berlin has now shown that, contrary to expectations, quantum fluctuations do not make the quasiparticle appear more clearly, but rather blur its signature.
- Graphene on titanium carbide triggers a novel phase transitionResearchers have discovered a Lifshitz-transition in TiC, driven by a graphene overlayer, at the photon source BESSY II. Their study sheds light on the exciting potential of 2D materials such as graphene and the effects they can have on neighboring materials through proximity interactions.